Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery

Area of Science:

• Pharmaceutical Sciences
• Nanotechnology
• Materials Science

Background:

• Transdermal drug delivery bypasses first-pass metabolism and improves patient compliance.
• Skin barrier presents significant challenges for effective drug permeation.
• Nanostructured lipid carriers (NLCs) represent an advancement over solid lipid nanoparticles (SLNs).

Purpose of the Study:

• To provide a comprehensive overview of NLCs for transdermal applications.
• To discuss NLCs' composition, production, and evaluation.
• To explore NLCs' potential for local and systemic drug delivery.

Main Methods:

• Review of NLCs' types, formulation strategies, and characterization techniques.
• Analysis of NLCs' permeation mechanisms across skin layers.
• Examination of recent advancements, patents, and industrial scalability.

Main Results:

• NLCs offer enhanced stability, higher drug loading, and controlled release compared to SLNs.
• NLCs demonstrate potential for overcoming skin barrier limitations.
• Significant research and patent activity highlight the growing interest in NLCs.

Conclusions:

• NLCs are safe, biodegradable nanocarriers with substantial potential for transdermal drug delivery.
• NLCs can address challenges in achieving effective local and systemic transdermal treatments.
• Further research into standardization and scale-up is crucial for clinical translation.